SV Health Investors

SV Health Investors (formerly SV Life Sciences) is a specialist healthcare venture capital and growth equity firm founded in 1993, with offices in Boston, MA and London, UK. The firm manages approximately $4.0B in historical commitments across dedicated, strategy-specific funds spanning three verticals: Therapeutics (seed through late-stage biotech, including precision medicine and dementia-focused funds such as the SV8 Biotech Fund with a $500M target and the Dementia Discovery Fund series); Healthcare Growth (growth-stage healthcare services, medical products, and digital health, targeting companies with at least $5M revenue near break-even); and Medtech (early-stage medical devices and remote-monitoring technologies via the $90M Medtech Convergence Fund). The firm typically leads or co-leads rounds and takes board seats. With a team of more than 50 investment professionals and operating partners, SV has backed over 75 IPOs and M&A exits across the US and UK. Entrepreneurs can reach the team via the contact page on the firm's website.